[NBIX] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
05-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -90.77%
YoY- -14.17%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 312,000 296,000 288,900 236,600 247,900 258,500 302,400 2.09%
PBT -13,800 30,500 57,500 27,200 41,700 -57,100 83,200 -
Tax -6,500 8,000 15,200 -4,900 -306,200 500 3,600 -
NP -7,300 22,500 42,300 32,100 347,900 -57,600 79,600 -
Tax Rate - -26.23% -26.43% 18.01% 734.29% - -4.33% -
Total Cost 319,300 273,500 246,600 204,500 -100,000 316,100 222,800 27.02%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -2.34 7.60 14.64 13.57 140.34 -22.28 26.32 -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -0.08 0.24 0.45 0.34 3.72 -0.62 0.86 -
EPS Diluted -0.08 0.23 0.43 0.33 3.58 -0.62 0.81 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.